Reference
Bernardini N, et al. Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema. Dermatology Reports 14: No. 4, 21 Nov 2022. Available from: URL: https://www.pagepress.org/journals/index.php/dr/article/view/9447
Rights and permissions
About this article
Cite this article
Acitretin/ciclosporin/steroids. Reactions Weekly 1940, 15 (2023). https://doi.org/10.1007/s40278-023-31873-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-31873-0